Skip to content
Peptigraph home

Tirzepatide for Muscle Growth: What the Evidence Shows

What human and animal studies show about Tirzepatide for muscle growth, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 / GIP dual agonistUpdated
Strongest evidence
Human RCT
Human studies
1
with an outcome for muscle growth, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
None found
with an outcome for muscle growth, in our evidence file (PubMed search, 2 Oct 2026)
Studies we summarised
2
with an outcome for muscle growth

Evidence for muscle growth

Each row is an outcome related to muscle growth from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Tirzepatide for muscle growth: outcomes in published studies
OutcomeResultStudy typeSource
Fat mass and lean massAt week 72, body weight, fat mass and lean mass changed by -21.3%, -33.9% and -10.9% with tirzepatide vs -5.3%, -8.2% and -2.6% with placebo.Human RCTn = 160Diabetes, obesity & metabolism 2025, PMID 39996356
Share of weight lost as fatAbout 75% of weight lost was fat mass and 25% lean mass, for both tirzepatide and placebo.Human RCTn = 160Diabetes, obesity & metabolism 2025, PMID 39996356
Lean mass loss with GLP-1 agonistsLean mass loss made up approximately 25% of total weight loss across the drug class.Meta-analysisn = 2258Metabolism: clinical and experimental 2025, PMID 39719170
Tirzepatide and lean massTirzepatide 15 mg weekly and semaglutide 2.4 mg weekly were most effective for weight and fat mass loss but among the least effective at preserving lean mass.Meta-analysisn = 2258Metabolism: clinical and experimental 2025, PMID 39719170

Tirzepatide and muscle growth are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 2 Oct 2026). Grades follow our evidence scale.

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4Diabetes, obesity & metabolism 2025, PMID 39996356

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Other peptides people research for muscle growth

CJC-1295CJC-1295 + IpamorelinSermorelinEnclomipheneHGHIGF-1 LR3hCGSemaglutide
All peptides for muscle growth, compared

Common questions

Does Tirzepatide help with muscle growth?

The strongest study we summarise for muscle growth is human rct evidence, across 2 studies with an outcome for muscle growth. A trial result is not an approval; see the legal status.

Is Tirzepatide approved for muscle growth?

Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for muscle growth?

There is no single answer. Our muscle growth overview compares each candidate by evidence grade and legal status rather than by popularity.

More on Tirzepatide

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Legal statusFDA, compounding and WADA status with dates.

Sources

  1. 1Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight.Diabetes, obesity & metabolism · 2025PMID 39996356Accessed 2 Oct 2026
  2. 2Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.Metabolism: clinical and experimental · 2025PMID 39719170Accessed 2 Oct 2026

Found an error? Report a correction.